Answers are grounded in this paper and cite their sources.
Biochemical sequence analysis reveals strong structural homology between NSILA and insulin B chain in human serum, suggesting a shared evolutionary origin.
The amino-terminal sequences of two polypeptides with nonsuppressible insulin-like and cell-growth-promoting activities (NSILA I and II), isolated from human serum, were determined. Of the first 31 residues, 22 are identical in NSILA I and II. Moreover, a striking structural similarity was found between NSILA and insulin B chain: 47 and 57% of residues 1-30 in NSILA I are identical to those in insulin B chain from man and tuna fish, respectively. This high degree of sequence identity is presented as evidence for homology and thus for a common evolutionary origin of insulin and NSILA. Based on these results and on these results and on biological properties of NSILA described earlier, a new designation for NSILA is proposed: insulin-like growth factor (IGF).
No takes yet. Share an insight, caveat, or question.
Rinderknecht et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: